肝炎の経過・予後 (肝炎をめぐって(シンポジウム))

スポンサーリンク

概要

• 論文の詳細を見る
• 北海道医学会の論文

著者

• 松島 喬

  北海道大学医学部内科学第三講座

関連論文

• 高感度PCR法を用いたHBVキャリアの病態別血中HBV DNA量の検討
• C型慢性肝炎(HCV RNA 1 Meq/ml以上症例)に対するインターフェロン治療の効果規定因子の検討
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• Significance of 2',5'-Oligoadenylate Synthetase Activity and HCV Genotype in IFN Therapy for Type C Chronic Hepatitis (Nagano Symposium 10)
• C型慢性肝炎におけけるインターフェロン投与開始24時間後のHCV RNA測定の意義
• 肝炎の経過・予後 (肝炎をめぐって(シンポジウム))
• 慢性B型肝炎に対するヒト白血球インターフェロンの効果

もっと見る 閉じる

スポンサーリンク